id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-N-0195-0002,FDA,FDA-2002-N-0195,"Agency Information Collection Activities; Announcement of OMB Approval; Blood Establishment Registration and Product Listing, Form FDA 2830",Notice,Notice of Approval,2003-03-17T05:00:00Z,2003,3,2003-03-17T05:00:00Z,,2025-05-08T23:22:32Z,03-6231,0,0,09000064804958a9
FDA-2002-N-0195-0001,FDA,FDA-2002-N-0195,"Agency Information Collection Activities; Submission for OMB Review; Comment Request; Blood Establishment Registration and Product Listing, Form FDA 2830",Notice,General Notice,2002-11-20T05:00:00Z,2002,11,2002-11-19T05:00:00Z,2002-12-20T04:59:59Z,2025-05-08T23:20:38Z,02-29295,0,0,09000064804958a1